Our study confirmed DIF as the preferred method for diagnosing BP. The addition of serological tests increases the diagnostic precision of DIF. Diagnosis of patients with clinical features compatible with BP may require the use of the BP180 NC16A ELISA test only in a specific setting of patients.
Pipitò et al. (Sun,) studied this question.